Supplements for the Treatment of Mild COVID-19-Challenging Health Beliefs With Science From A to Z
JAMA Netw Open
.
2021 Feb 1;4(2):e210431.
doi: 10.1001/jamanetworkopen.2021.0431.
Authors
Erin D Michos
1
2
,
Miguel Cainzos-Achirica
3
4
Affiliations
1
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland.
2
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
3
Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas.
4
Center for Outcomes Research, Houston Methodist, Houston, Texas.
PMID:
33576814
DOI:
10.1001/jamanetworkopen.2021.0431
No abstract available
Publication types
Comment
MeSH terms
Ascorbic Acid
COVID-19*
Dietary Supplements
Humans
SARS-CoV-2*
Zinc
Substances
Zinc
Ascorbic Acid